LSRI DROPPED TO PINK SHEETS AS ACTIVIST’S TRIAL BEGINS IN NJ

For Immediate Release – February 7, 2006
Attention: Financial/Business

LSRI DROPPED TO PINK SHEETS AS ACTIVIST’S TRIAL BEGINS IN NJ

New York, NY- On the eve of a landmark free speech trial in Trenton, NJ, the campaign to Stop Huntingdon Animal Cruelty (SHAC) notched an important victory against the beleaguered animal testing lab. Last week, Huntingdon Life Sciences (HLS), which traded on the Over The Counter Bulletin Board as Life Sciences Research Inc. (Symbol – LSRI) was dropped down to the Pink Sheets, due to the resignation of their only market maker, Legacy Trading (Symbol – LGTD).

New York activist group Win Animal Rights (WAR) has spearheaded the campaign against the supporters of HLS in New York’s financial district. WAR has taken the fight against Huntingdon Life Sciences to the prestigious Wall Street and posh midtown Manhattan offices of HLS investors, market makers and customers, and has included the controversial tactic of aggressively protesting at the homes of influential key executives of targeted companies.

Camille Hankins of Win Animal Rights commented on the financial plight of LSRI: “We were pleased when LSRI was dropped by the NYSE in September, and we have seen them fall all the way to the Pink Sheets less than 5 months later. Huntingdon Life Sciences is a morally bankrupt company that profits from the suffering and killing of 500 animals every day.” Hankins adds: “We will not rest until Huntingdon Life Sciences is financially bankrupt as well and the killing of defenseless animals ends.”

On Monday, February 6, 2006, as the trial of the “SHAC 7” began in New Jersey, WAR activists have chosen to support their fellow activists by pressing forward with the campaign to influence HLS financial backers, instead of attending the courthouse rallies. WAR will be staging protests at the offices of one of LSRI’s major investors, Columbia Management, subsidiary of Bank of America, as well as various customers of HLS including Pfizer, Novartis, Roche and GlaxoSmithKline. Protests will be held at both office and home locations.

Greg Kelly of Win Animal Rights stated the following about the important implications of the trial of the SHAC 7: “The federal case that will be decided in Trenton is not just about the SHAC 7. It is about all of us and our ability to effectively work for animal rights, human rights, peace or whatever cause we wish to champion. It is important that we do everything we can to send a message that we will not be coerced or intimidated. We will continue to fight despite government repression.”